Plant Comparison
Birch vs Perforate St John’s-wort
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Birch and Perforate St John’s-wort: they share 7 indicated uses (arthritis / joint pain, cold & flu, eczema, …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Birch | Perforate St John’s-wort | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cold & flu | 1/10 | 1/10 | Comparable evidence |
| Eczema | 1/10 | 1/10 | Comparable evidence |
| Infection (general) | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Principal diuretic and antioxidant constituents of the leaf.
Characteristic bark triterpenes, betulin giving birch bark its white colour; studied for anticancer and anti-inflammatory activity.
Contribute to the astringent and antioxidant properties of the bark and leaf.
Red pigments historically used to standardise extracts; contribute to antiviral activity and are the compounds responsible for photosensitivity risk.
Considered the principal compound behind the antidepressant activity and the main driver of the herb's potent CYP3A4/P-glycoprotein induction and drug-interaction profile.
Antioxidant flavonoids contributing to overall activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from gastroprotective action
inferred from anti-inflammatory action
inferred from anti-rheumatic action
inferred from antidiabetic action
inferred from anticancer action
inferred from gastroprotective action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
inferred from diuretic action
inferred from anti-inflammatory action
inferred from antiviral action
inferred from anti-inflammatory action
inferred from sedative action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally considered safe when used appropriately. Side effects may include diarrhea, nausea, and allergic reactions (itching, rash, stuffy nose). Not recommended for individuals with edema caused by heart or kidney dysfunction. Ensure adequate fluid intake when using as a diuretic. Frequency of side effects is unknown.
Duke (2002) provides clinical evidence (score 2) for birch leaf's diuretic activity, as well as for its use in urinary gravel, kidney stones, and rheumatic conditions — consistent with Commission E (KOM) and German Phytotherapy (PIP) approvals. It acts as an aquaretic, increasing urine volume without electrolyte loss. Antimelanomic activity has been demonstrated in experimental studies. The plant has a good safety profile and is classified as non-toxic at usual therapeutic doses (Duke, 2002).
Significant drug interactions: strongly induces CYP3A4 and P-glycoprotein, reducing plasma levels of many drugs including oral contraceptives, antiretrovirals, cyclosporine, warfarin, and digoxin. May cause photosensitivity (fair-skinned individuals). Do not combine with SSRIs, SNRIs, or MAOIs (serotonin syndrome risk). Avoid in bipolar disorder.
Duke (2002) rates St. John's wort as ++ (raised from earlier editions) and notes antidepressant, antiviral, antibacterial, and wound-healing activities at experimental and clinical levels. Hypericin and hyperforin are identified as key active constituents. Clinical evidence (score 2) confirms antidepressant efficacy in mild-to-moderate depression, and WHO/Commission E provide approval for this indication. Dose: 300 mg standardized extract (0.3% hypericin, 3–5% hyperforin) three times daily. Duke emphasizes the critical drug interaction: St. John's wort is a potent CYP3A4 inducer and can significantly reduce blood levels of many medications including oral contraceptives, cyclosporine, antiretrovirals, and warfarin. Avoid combined use with SSRIs (serotonin syndrome risk) and pharmaceutical antidepressants (Duke, 2002).
External Ids
Botanical Description
Elegant deciduous tree with a slender trunk, distinctive smooth white bark that peels in papery horizontal strips and becomes dark and fissured near the base with age, and characteristically drooping ('pendulous') branchlets. The leaves are small, triangular to diamond-shaped, doubly toothed and long-pointed. Male and female flowers are borne in separate catkins on the same tree in spring.[1]
Erect, branching perennial herb with paired, oval leaves dotted with tiny translucent oil glands that look like pinpricks when held to the light (giving the species name 'perforatum'). Bright yellow, five-petalled flowers with numerous stamens and black dots along the petal edges are borne in flat-topped clusters, and release a reddish pigment when crushed.[4]
Habitat
A pioneer tree of light, well-drained, often poor or acidic soils, growing in woodland, heathland and waste ground across Europe and much of temperate Asia.[1]
Grows in grassland, roadsides, woodland clearings and waste ground on well-drained soils; native to Europe, Western Asia and North Africa and widely naturalised elsewhere, including North America and Australia.[4]
Harvesting
Leaves are picked in spring and early summer while young and tender; bark is collected from felled or fallen wood (living trees should not be stripped of bark, which can kill them); sap is tapped in early spring, before leaf-out, through a small hole bored in the trunk.[1]
The flowering tops (flower and upper leaf) are cut in summer as the flowers open, around the traditional St John's Day period, and dried quickly in a warm, shaded, airy place to preserve the hypericin and hyperforin content.[4]
Traditional Uses
Birch leaf is a classic European 'aquaretic' diuretic used for urinary gravel, kidney stones and as a spring detoxifying tonic, and for rheumatic and joint complaints; the bark and its extracts have a long folk history for skin conditions, while the sap has been drunk fresh as a traditional spring tonic.[1]
St John's wort has a centuries-long European folk reputation as a wound-healing and nerve tonic herb, traditionally used for mild wounds, burns and nerve pain and to lift low mood; this traditional mood-supporting use is now one of the most extensively clinically studied applications of any herbal medicine, with standardised extracts shown comparable to conventional antidepressants for mild-to-moderate depression.[1, 4]
Preparations
Flowering-top extract standardised to hypericin and/or hyperforin content, taken as tablets or capsules; the best-studied clinical form for mood support.
Dosage
The EU herbal monograph gives 2-3 g of the comminuted leaf in 150 mL of boiling water as an infusion, up to 4 times daily, in adolescents, adults and elderly, with adequate fluid intake; dry extract at 0.25-1 g 4 times daily and liquid extract at 15 mL 2-3 times daily are also listed. Traditionally used over a period of 2-4 weeks. Not recommended under 12 years. Educational reference only, not a prescription.
Clinical trials for mild-to-moderate depression commonly use around 300 mg of standardised extract three times daily (900 mg/day total); given extensive drug interactions, use should be discussed with a healthcare provider, especially alongside other medicines. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
Pairings
Not documented
St John's wort raises serotonin activity and can cause serotonin syndrome when combined with other serotonin-boosting agents; pairing it with another mood-active, serotonergic herb such as saffron may add to this risk.[30]
St John's wort is a strong enzyme inducer and increases serotonin activity; combining it with another antidepressant-type herb such as rhodiola may add to serotonergic effects and unpredictably change how each is handled by the body.[30]
St John's wort speeds up the breakdown of many substances and also raises serotonin activity; pairing it with a sedative herb such as valerian may add to drowsiness and can unpredictably change how each is handled by the body.[30, 31]
St John's wort is a strong enzyme inducer and kava is a liver-metabolised sedative; combining them may add to central-nervous-system effects and alter how kava is processed, so combined use warrants caution.[30, 31]
References & Sources
- Rastogi, S., Pandey, M.M. and Kumar Singh Rawat, A (2014) 'Medicinal plants of the genus Betula — traditional uses and a phytochemical-pharmacological review', Journal of Ethnopharmacology, 159, pp. 62-83. doi:10.1016/j.jep.2014.11.010 Traditional / reference
https://doi.org/10.1016/j.jep.2014.11.010 - Penkov, D., Andonova, V., Delev, D. and Kostadinov, I (2018) 'Antioxidant Activity of Dry Birch (Betula pendula) Leaves Extract', Folia Medica, 60(4), pp. 571-579. doi:10.2478/folmed-2018-0035 Preclinical
https://doi.org/10.2478/folmed-2018-0035 - Sevastre-Berghian, A.C., Ielciu, I., Bab, T., Olah, N.K. et al (2023) 'Betula pendula Leaf Extract Targets the Interplay between Brain Oxidative Stress, Inflammation, and NF-kB Pathways in Amyloid Abeta-Treated Rats', Antioxidants (Basel), 12(12), pp. 2110. doi:10.3390/antiox12122110 Preclinical
https://doi.org/10.3390/antiox12122110 - Grundemann, C., Gruber, C.W., Hertrampf, A., Zehl, M., Kopp, B. and Huber, R (2011) 'An aqueous birch leaf extract of Betula pendula inhibits the growth and cell division of inflammatory lymphocytes', Journal of Ethnopharmacology, 136(3), pp. 444-451. doi:10.1016/j.jep.2011.05.018 Preclinical
https://doi.org/10.1016/j.jep.2011.05.018 - Azman, N.A.M., Skowyra, M., Muhammad, K., Gallego, M.G. and Almajano, M.P (2017) 'Evaluation of the antioxidant activity of Betula pendula leaves extract and its effects on model foods', Pharmaceutical Biology, 55(1), pp. 912-919. doi:10.1080/13880209.2017.1282528 Preclinical
https://doi.org/10.1080/13880209.2017.1282528 - Bljajic, K., Sostaric, N., Petlevski, R., Vujic, L., Brajkovic, A. and Fumic, B (2016) 'Effect of Betula pendula Leaf Extract on alpha-Glucosidase and Glutathione Level in Glucose-Induced Oxidative Stress', Evidence-Based Complementary and Alternative Medicine, 2016, pp. 8429398. doi:10.1155/2016/8429398 Preclinical
https://doi.org/10.1155/2016/8429398 - Ou-Yang, T., Zhang, Y., Luo, H.Z., Liu, Y. and Ma, S.C (2023) 'Novel compounds discovery approach based on UPLC-QTOF-MS/MS chemical profile reveals birch bark extract anti-inflammatory, -oxidative, and -proliferative effects', Journal of Ethnopharmacology, 309, pp. 116148. doi:10.1016/j.jep.2023.116148 Preclinical
https://doi.org/10.1016/j.jep.2023.116148 - Szoka, L., Nazaruk, J., Stocki, M. and Isidorov, V (2021) 'Santin and cirsimaritin from Betula pubescens and Betula pendula buds induce apoptosis in human digestive system cancer cells', Journal of Cellular and Molecular Medicine, 25(23), pp. 11085-11096. doi:10.1111/jcmm.17031 Preclinical
https://doi.org/10.1111/jcmm.17031 - Isidorov, V., Szoka, L. and Nazaruk, J (2018) 'Cytotoxicity of white birch bud extracts: Perspectives for therapy of tumours', PLoS One, 13(8), pp. e0201949. doi:10.1371/journal.pone.0201949 Preclinical
https://doi.org/10.1371/journal.pone.0201949 - Efthimiou, I., Vlastos, D., Triantafyllidis, V., Eleftherianos, A. and Antonopoulou, M (2022) 'Investigation of the Genotoxicological Profile of Aqueous Betula pendula Extracts', Plants, 11(20), pp. 2673. doi:10.3390/plants11202673 Preclinical
https://doi.org/10.3390/plants11202673 - Jafari Hajati, R., Payamnoor, V., Ahmadian Chashmi, N. and Ghasemi Bezdi, K (2018) 'Improved accumulation of betulin and betulinic acid in cell suspension culture of Betula pendula Roth by abiotic and biotic elicitors', Preparative Biochemistry & Biotechnology, 48(10), pp. 915-924. doi:10.1080/10826068.2018.1514514 Preclinical
https://doi.org/10.1080/10826068.2018.1514514 - European Medicines Agency (HMPC) (2015) 'European Union herbal monograph on Betula pendula Roth and/or Betula pubescens Ehrh. as well as hybrids of both species, folium'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-betula-pendula-roth-betula-pubescens-ehrh-folium_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-betula-pendula-roth-betula-pubescens-ehrh-folium_en.pdf - European Medicines Agency (HMPC) (2015) 'Birch leaf (Betulae folium): summary for the public'. Available at: https://www.ema.europa.eu/en/documents/herbal-summary/birch-leaf-summary-public_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-summary/birch-leaf-summary-public_en.pdf - Oszmiański J, et al. Evaluating birch leaf tea as a functional herbal beverage. Food Res Int. 2024. https://www.sciencedirect.com/science/article/abs/pii/S0963996924005519 https://pmc.ncbi.nlm.nih.gov/articles/PMC7126499/ (2024) 'https://www.sciencedirect.com/science/article/abs/pii/S0963996924005519 https://pmc.ncbi.nlm.nih.gov/articles/PMC7126499/'. Available at: https://www.sciencedirect.com/science/article/abs/pii/S0963996924005519 Traditional / reference
https://www.sciencedirect.com/science/article/abs/pii/S0963996924005519 - Rastogi S, Pandey MM, Rawat AKS. Medicinal plants of the genus Betula—Traditional uses and a phytochemical–pharmacological review. J Ethnopharmacol. 2015;159:62-83. https://pmc.ncbi.nlm.nih.gov/articles/PMC7126499/ (2015) ';159:62-83'. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7126499/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC7126499/ - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Ng, Q.X., Venkatanarayanan, N. and Ho, C.Y.X (2017) 'Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis', Journal of Affective Disorders, 210, pp. 211-221. doi:10.1016/j.jad.2016.12.048 Meta-analysis / review
https://doi.org/10.1016/j.jad.2016.12.048 - Kholghi, G., Arjmandi-Rad, S., Zarrindast, M.R. and Vaseghi, S (2022) 'St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?', Naunyn-Schmiedeberg's Archives of Pharmacology, 395(6), pp. 629-642. doi:10.1007/s00210-022-02229-z Traditional / reference
https://doi.org/10.1007/s00210-022-02229-z - Fugh-Berman, A (2000) 'Herb-drug interactions', Lancet, 355(9198), pp. 134-138. doi:10.1016/S0140-6736(99)06457-0 Traditional / reference
https://doi.org/10.1016/S0140-6736(99)06457-0 - Nobakht, S.Z., Akaberi, M., Mohammadpour, A.H., Tafazoli Moghadam, A. and Emami, S.A (2022) 'Hypericum perforatum: Traditional uses, clinical trials, and drug interactions', Iranian Journal of Basic Medical Sciences, 25(9), pp. 1045-1058. doi:10.22038/IJBMS.2022.65112.14338 Meta-analysis / review
https://doi.org/10.22038/IJBMS.2022.65112.14338 - Jiang, Z., Wang, F., Zhao, Y., Lu, L., Jiang, X., Huang, T., Lin, Y., Guo, L., Weng, Z. and Liu, E (2024) 'Hypericum perforatum L. attenuates depression by regulating Akkermansia muciniphila, tryptophan metabolism and NFkB-NLRP2-Caspase1-IL1beta pathway', Phytomedicine, 132, pp. 155847. doi:10.1016/j.phymed.2024.155847 Preclinical
https://doi.org/10.1016/j.phymed.2024.155847 - Oliveira, A.I., Pinho, C., Sarmento, B. and Dias, A.C.P (2016) 'Neuroprotective Activity of Hypericum perforatum and Its Major Components', Frontiers in Plant Science, 7, pp. 1004. doi:10.3389/fpls.2016.01004 Meta-analysis / review
https://doi.org/10.3389/fpls.2016.01004 - Russo, E., Scicchitano, F., Whalley, B.J., Mazzitello, C., Ciriaco, M., Esposito, S., Patane, M., Upton, R., Pugliese, M., Chimirri, S., Mammi, M., Palleria, C. and De Sarro, G (2013) 'Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions', Phytotherapy Research, 28(5), pp. 643-655. doi:10.1002/ptr.5050 Meta-analysis / review
https://doi.org/10.1002/ptr.5050 - Saddiqe, Z., Naeem, I. and Maimoona, A (2010) 'A review of the antibacterial activity of Hypericum perforatum L', Journal of Ethnopharmacology, 131(3), pp. 511-521. doi:10.1016/j.jep.2010.07.034 Meta-analysis / review
https://doi.org/10.1016/j.jep.2010.07.034 - Mennini, T. and Gobbi, M (2004) 'The antidepressant mechanism of Hypericum perforatum', Life Sciences, 75(9), pp. 1021-1027. doi:10.1016/j.lfs.2004.04.005 Meta-analysis / review
https://doi.org/10.1016/j.lfs.2004.04.005 - Liu, Y., Jiang, Y., Huang, R., Yang, J., Xiao, B. and Dong, J (2013) 'Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety', Climacteric, 17(4), pp. 325-335. doi:10.3109/13697137.2013.861814 Meta-analysis / review
https://doi.org/10.3109/13697137.2013.861814 - Wurglics, M. and Schubert-Zsilavecz, M (2006) 'Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients', Clinical Pharmacokinetics, 45(5), pp. 449-468. doi:10.2165/00003088-200645050-00002 Meta-analysis / review
https://doi.org/10.2165/00003088-200645050-00002 - Kasper, S (2001) 'Hypericum perforatum - a review of clinical studies', Pharmacopsychiatry, 34(Suppl 1), pp. S51-S55. doi:10.1055/s-2001-15467 Meta-analysis / review
https://doi.org/10.1055/s-2001-15467 - Nathan, P (1999) 'The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.)', Molecular Psychiatry, 4(4), pp. 333-338. doi:10.1038/sj.mp.4000557 Meta-analysis / review
https://doi.org/10.1038/sj.mp.4000557 - Verotta, L (2003) 'Hypericum perforatum, a source of neuroactive lead structures', Current Topics in Medicinal Chemistry, 3(2), pp. 187-201. doi:10.2174/1568026033392589 Meta-analysis / review
https://doi.org/10.2174/1568026033392589 - Linde, K. et al (2008) 'St John'. Traditional / reference
https://scholar.google.com/scholar?q=St%20John - Natural Standard (2013) 'Hypericum perforatum (St'. Traditional / reference
https://scholar.google.com/scholar?q=Hypericum%20perforatum%20%28St - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Zhou, S., Chan, E., Pan, S.Q., Huang, M. and Lee, E.J.D (2004) 'Pharmacokinetic interactions of drugs with St John's wort', Journal of Psychopharmacology, 18(2), pp. 262-276. doi:10.1177/0269881104042632 Meta-analysis / review
https://doi.org/10.1177/0269881104042632 - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Borrelli, F. and Izzo, A.A (2009) 'Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations', The AAPS Journal, 11(4), pp. 710-727. doi:10.1208/s12248-009-9146-8 Meta-analysis / review
https://doi.org/10.1208/s12248-009-9146-8 - Nicolussi, S., Drewe, J., Butterweck, V. and Meyer zu Schwabedissen, H.E (2020) 'Clinical relevance of St. John's wort drug interactions revisited', British Journal of Pharmacology, 177(6), pp. 1212-1226. doi:10.1111/bph.14936 Meta-analysis / review
https://doi.org/10.1111/bph.14936 - Piscitelli, S.C., Burstein, A.H., Chaitt, D., Alfaro, R.M. and Falloon, J (2000) 'Indinavir concentrations and St John's wort', Lancet, 355(9203), pp. 547-548. doi:10.1016/S0140-6736(99)05712-8 Clinical study
https://doi.org/10.1016/S0140-6736(99)05712-8 - Barone, G.W., Gurley, B.J., Ketel, B.L., Lightfoot, M.L. and Abul-Ezz, S.R (2000) 'Drug interaction between St. John's wort and cyclosporine', Annals of Pharmacotherapy, 34(9), pp. 1013-1016. doi:10.1345/aph.10088 Clinical study
https://doi.org/10.1345/aph.10088 - Murphy, P.A., Kern, S.E., Stanczyk, F.Z. and Westhoff, C.L (2005) 'Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding', Contraception, 71(6), pp. 402-408. doi:10.1016/j.contraception.2004.11.004 Clinical study
https://doi.org/10.1016/j.contraception.2004.11.004 - Murphy, P.A., Kern, S.E., Stanczyk, F.Z. and Westhoff, C.L (2005) 'Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding', Contraception, 71(6), pp. 402-408. doi:10.1016/j.contraception.2004.11.004 Clinical study
https://doi.org/10.1016/j.contraception.2004.11.004 - Pfrunder, A., Schiesser, M., Gerber, S., Haschke, M., Bitzer, J. and Drewe, J (2003) 'Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial', British Journal of Clinical Pharmacology, 56(6), pp. 683-690. doi:10.1046/j.1365-2125.2003.02005.x Randomized trial
https://doi.org/10.1046/j.1365-2125.2003.02005.x - Johne, A., Brockmoller, J., Bauer, S., Maurer, A., Langheinrich, M. and Roots, I (1999) 'Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)', Clinical Pharmacology and Therapeutics, 66(4), pp. 338-345. doi:10.1053/cp.1999.v66.a101944 Clinical study
https://doi.org/10.1053/cp.1999.v66.a101944 - Mathijssen, R.H.J., Verweij, J., de Bruijn, P., Loos, W.J. and Sparreboom, A (2002) 'Effects of St. John's wort on irinotecan metabolism', Journal of the National Cancer Institute, 94(16), pp. 1247-1249. doi:10.1093/jnci/94.16.1247 Randomized trial
https://doi.org/10.1093/jnci/94.16.1247 - Smith, P., Bullock, J.M., Booker, B.M., Haas, C.E., Berenson, C.S. and Jusko, W.J (2004) 'The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate', Pharmacotherapy, 24(11), pp. 1508-1514. doi:10.1592/phco.24.16.1508.50958 Clinical study
https://doi.org/10.1592/phco.24.16.1508.50958 - Izzo, A.A (2004) 'Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence', International Journal of Clinical Pharmacology and Therapeutics, 42(3), pp. 139-148. doi:10.5414/cpp42139 Meta-analysis / review
https://doi.org/10.5414/cpp42139 - Caus, M.N., Lupoae, M. and Chitescu, C.L (2026) 'Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks', Pharmaceuticals, 19(3), pp. 399. doi:10.3390/ph19030399 Meta-analysis / review
https://doi.org/10.3390/ph19030399
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.